Teriparatide
Indication
Secondary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA161) and men (NHSE policy)
Red
Brand:
Nice TA:
161
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Endocrine system
Background
For specialist use only in accordance with NICE TA guidance (women) or NHS England commissioning policy (men)
NHSE: Clinical Commissioning Policy: Teriparatide for Osteoporosis in Men (Adults) document